The Food and Drug Administration (FDA) has reopened its public comment period on ways the agency can enhance the transparency of FDA activities and decisionmaking. Specifically, the FDA will accept comments on this topic until November 6, 2009 in preparation for a second meeting of the FDA’s Transparency Task Force planned for this fall.